IPO Pipeline Update: BJ’s Wholesale files for IPO

IPO Boutique keeps apprised of the active pipeline. Currently there are 57 active IPOs in the pipeline as of May 18, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article.

NEW FILINGS

Company: M17 Entertainment Limited
Symbol: YQ
Description: They operate the largest live streaming platform by revenue in Developed Asia with a market share of 19.2% in the first quarter of 2018, according to Frost & Sullivan.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Citigroup, Deutsche Bank Securities
Co-Manager(s): Daiwa Capital Markets, Mizuho Securities
Terms Added: 5-11-18
Listed Cash Raise: $115m

Company: MeiraGTx Holdings plc
Symbol: MGTX
Description: They are a vertically integrated, clinical stage gene therapy company with four ongoing clinical programs and a broad pipeline of preclinical and research programs.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): BofA Merrill Lynch, Barclays, Evercore ISI
Co-Manager(s): Chardan
Terms Added: 5-14-18
Listed Cash Raise: $86.25m

Company: BJ’s Wholesale Club Holdings, Inc.
Symbol: BJ
Description: BJ’s Wholesale Club is a leading warehouse club operator on the East Coast of the United States.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): BofA Merrill Lynch, Deutsche Bank, Goldman Sachs, J.P. Morgan
Filed: 5-17-18
Listed Cash Raise: $100m

Company: Adaptive Insights, Inc.
Symbol: ADIN
Description: They are a leading provider of cloud-based software to modernize business planning.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Jefferies, RBC Capital
Co-Manager(s): JMP Securities, Oppenheimer & Co.
Filed: 5-17-18
Listed Cash Raise: $100m

TERMS ADDED

Company: Scholar Rock Holding Corporation
Symbol: SRRK
Description: They are a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
Trade Date: 5/24
Shares: 5.36 million
Price Range: $13.00-$15.00
Underwriter(s): Jefferies, Cowen, BMO Capital
Co-Manager(s): Wedbush PacGrow
Terms Added: 5-14-18

Company: Kiniksa Pharmaceuticals, Ltd.
Symbol: KNSA
Description: They are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
Trade Date: 5/24
Shares: 7 million
Price Range: $17.00-$19.00
Underwriter(s): Goldman Sachs, J.P. Morgan
Co-Manager(s): JMP Securities, Wedbush PacGrow
Terms Added: 5-14-18

Company: GreenSky, Inc.
Symbol: GSKY
Description: They are a leading technology company that powers commerce at the point of sale.
Trade Date: 5/24
Shares: 34.1 million
Price Range: $21.00-$23.00
Underwriter(s): Goldman Sachs & Co., J.P. Morgan, Morgan Stanley, BofA Merrill Lynch, Citigroup, Credit Suisse, SunTrust Robinson Humphrey
Co-Manager(s): Raymond James, Sandler O’ Neill, Fifth Third Securities, Guggenheim Securities
Terms Added: 5-14-18

Company: Iterum Therapeutics plc
Symbol: ITRM
Description: They are a pharmaceutical company dedicated to developing and commercializing sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available globally.
Trade Date: 5/25
Shares: 5.33 million
Price Range: $14.00-$16.00
Underwriter(s): Leerink Partners, RBC Capital Partners
Co-Manager(s): Guggenheim Securities, Needham & Co.
Terms Added: 5-16-18